img

Global Injectable Peptides Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Injectable Peptides Market Insights, Forecast to 2034

Peptide-based injectable drugs refer to medications that contain peptides as their active ingredients and are administered via injection. Peptides are short chains of amino acids, which are the building blocks of proteins. They play crucial roles in various biological processes and can be used therapeutically to target specific cellular pathways or receptors.
Market Analysis and InsightsGlobal Injectable Peptides Market
Global Injectable Peptides market is expected to reach to US$ 33880 million in 2024, with a positive growth of %, compared with US$ 32150 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Injectable Peptides industry is evaluated to reach US$ 43610 million in 2034. The CAGR will be 4.3% during 2024 to 2034.
Injectable peptide drugs offer several advantages over other administration routes, such as oral or topical delivery. When injected, peptides can bypass the gastrointestinal tract, avoiding issues such as degradation by stomach acid or poor absorption. Additionally, injections can provide a more rapid and direct delivery of the drug into the bloodstream, allowing for faster onset of action.
Report Covers
This report presents an overview of global Injectable Peptides market from 2024 to 2034, aiming to help readers to get a comprehensive understanding of global Injectable Peptides market with multiple angles. Items like regional revenue from 2024 to 2034 and companies’ revenue and gross margin from 2024 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2024 to 2034 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Sanofi
Teva
Novo Nordisk
Takeda
Eli Lilly
AstraZeneca
Novartis
AbbVie
Ipsen
Ferring
Merck
The Medicines
Roche
J & J
Segment by Type
Brand
Generic Drug

Segment by Application


Cancer
Metabolic Disorders
Central Nervous System
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2024 to 2034
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2024 to 2034 globally
Chapter 5Product revenue analysis by application from 2024 to 2034 globally
Chapter 6Product revenue analysis by type and application from 2024 to 2034 in US & Canada. Product revenue analysis of each country in US & Canada from 2024 to 2034
Chapter 7Product revenue analysis by type and application from 2024 to 2034 in Europe. Product revenue analysis of each country in Europe from 2024 to 2034
Chapter 8Product revenue analysis by type and application from 2024 to 2034 in China. Product revenue analysis of China from 2024 to 2034
Chapter 9Product revenue analysis by type and application from 2024 to 2034 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2024 to 2034
Chapter 10Product revenue analysis by type and application from 2024 to 2034 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2024 to 2034.
Chapter 11Companies’ outline, covering company’s basic information, major business, Injectable Peptides introduction, etc. Injectable Peptides Revenue and Gross Margin of each company from 2024 to 2024
Chapter 12Mr Accuracy reports’s Conclusions of Injectable Peptides
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Injectable Peptides Market Size Growth Rate by Type, 2024 VS 2022 VS 2034
1.2.2 Brand
1.2.3 Generic Drug
1.3 Market by Application
1.3.1 Global Injectable Peptides Market Size Growth Rate by Application, 2024 VS 2022 VS 2034
1.3.2 Cancer
1.3.3 Metabolic Disorders
1.3.4 Central Nervous System
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Injectable Peptides Market Perspective (2024-2034)
2.2 Global Injectable Peptides Growth Trends by Region
2.2.1 Injectable Peptides Market Size by Region: 2024 VS 2022 VS 2034
2.2.2 Injectable Peptides Historic Market Size by Region (2024-2024)
2.2.3 Injectable Peptides Forecasted Market Size by Region (2024-2034)
2.3 Injectable Peptides Market Dynamics
2.3.1 Injectable Peptides Industry Trends
2.3.2 Injectable Peptides Market Drivers
2.3.3 Injectable Peptides Market Challenges
2.3.4 Injectable Peptides Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Injectable Peptides by Players
3.1.1 Global Injectable Peptides Revenue by Players (2024-2024)
3.1.2 Global Injectable Peptides Revenue Market Share by Players (2024-2024)
3.2 Global Injectable Peptides Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Injectable Peptides, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Injectable Peptides Market Concentration Ratio
3.4.1 Global Injectable Peptides Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Injectable Peptides Revenue in 2022
3.5 Global Key Players of Injectable Peptides Head office and Area Served
3.6 Global Key Players of Injectable Peptides, Product and Application
3.7 Global Key Players of Injectable Peptides, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Injectable Peptides Breakdown Data by Type
4.1 Global Injectable Peptides Historic Market Size by Type (2024-2024)
4.2 Global Injectable Peptides Forecasted Market Size by Type (2024-2034)
5 Injectable Peptides Breakdown Data by Application
5.1 Global Injectable Peptides Historic Market Size by Application (2024-2024)
5.2 Global Injectable Peptides Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Injectable Peptides Market Size (2024-2034)
6.2 North America Injectable Peptides Market Size by Type
6.2.1 North America Injectable Peptides Market Size by Type (2024-2024)
6.2.2 North America Injectable Peptides Market Size by Type (2024-2034)
6.2.3 North America Injectable Peptides Market Share by Type (2024-2034)
6.3 North America Injectable Peptides Market Size by Application
6.3.1 North America Injectable Peptides Market Size by Application (2024-2024)
6.3.2 North America Injectable Peptides Market Size by Application (2024-2034)
6.3.3 North America Injectable Peptides Market Share by Application (2024-2034)
6.4 North America Injectable Peptides Market Size by Country
6.4.1 North America Injectable Peptides Market Size by Country: 2024 VS 2022 VS 2034
6.4.2 North America Injectable Peptides Market Size by Country (2024-2024)
6.4.3 North America Injectable Peptides Market Size by Country (2024-2034)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Injectable Peptides Market Size (2024-2034)
7.2 Europe Injectable Peptides Market Size by Type
7.2.1 Europe Injectable Peptides Market Size by Type (2024-2024)
7.2.2 Europe Injectable Peptides Market Size by Type (2024-2034)
7.2.3 Europe Injectable Peptides Market Share by Type (2024-2034)
7.3 Europe Injectable Peptides Market Size by Application
7.3.1 Europe Injectable Peptides Market Size by Application (2024-2024)
7.3.2 Europe Injectable Peptides Market Size by Application (2024-2034)
7.3.3 Europe Injectable Peptides Market Share by Application (2024-2034)
7.4 Europe Injectable Peptides Market Size by Country
7.4.1 Europe Injectable Peptides Market Size by Country: 2024 VS 2022 VS 2034
7.4.2 Europe Injectable Peptides Market Size by Country (2024-2024)
7.4.3 Europe Injectable Peptides Market Size by Country (2024-2034)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Injectable Peptides Market Size (2024-2034)
8.2 China Injectable Peptides Market Size by Type
8.2.1 China Injectable Peptides Market Size by Type (2024-2024)
8.2.2 China Injectable Peptides Market Size by Type (2024-2034)
8.2.3 China Injectable Peptides Market Share by Type (2024-2034)
8.3 China Injectable Peptides Market Size by Application
8.3.1 China Injectable Peptides Market Size by Application (2024-2024)
8.3.2 China Injectable Peptides Market Size by Application (2024-2034)
8.3.3 China Injectable Peptides Market Share by Application (2024-2034)
9 Asia (excluding China)
9.1 Asia Injectable Peptides Market Size (2024-2034)
9.2 Asia Injectable Peptides Market Size by Type
9.2.1 Asia Injectable Peptides Market Size by Type (2024-2024)
9.2.2 Asia Injectable Peptides Market Size by Type (2024-2034)
9.2.3 Asia Injectable Peptides Market Share by Type (2024-2034)
9.3 Asia Injectable Peptides Market Size by Application
9.3.1 Asia Injectable Peptides Market Size by Application (2024-2024)
9.3.2 Asia Injectable Peptides Market Size by Application (2024-2034)
9.3.3 Asia Injectable Peptides Market Share by Application (2024-2034)
9.4 Asia Injectable Peptides Market Size by Region
9.4.1 Asia Injectable Peptides Market Size by Region: 2024 VS 2022 VS 2034
9.4.2 Asia Injectable Peptides Market Size by Region (2024-2024)
9.4.3 Asia Injectable Peptides Market Size by Region (2024-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Injectable Peptides Market Size (2024-2034)
10.2 Middle East, Africa, and Latin America Injectable Peptides Market Size by Type
10.2.1 Middle East, Africa, and Latin America Injectable Peptides Market Size by Type (2024-2024)
10.2.2 Middle East, Africa, and Latin America Injectable Peptides Market Size by Type (2024-2034)
10.2.3 Middle East, Africa, and Latin America Injectable Peptides Market Share by Type (2024-2034)
10.3 Middle East, Africa, and Latin America Injectable Peptides Market Size by Application
10.3.1 Middle East, Africa, and Latin America Injectable Peptides Market Size by Application (2024-2024)
10.3.2 Middle East, Africa, and Latin America Injectable Peptides Market Size by Application (2024-2034)
10.3.3 Middle East, Africa, and Latin America Injectable Peptides Market Share by Application (2024-2034)
10.4 Middle East, Africa, and Latin America Injectable Peptides Market Size by Country
10.4.1 Middle East, Africa, and Latin America Injectable Peptides Market Size by Country: 2024 VS 2022 VS 2034
10.4.2 Middle East, Africa, and Latin America Injectable Peptides Market Size by Country (2024-2024)
10.4.3 Middle East, Africa, and Latin America Injectable Peptides Market Size by Country (2024-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Injectable Peptides Introduction
11.1.4 Sanofi Revenue in Injectable Peptides Business (2024-2024)
11.1.5 Sanofi Recent Developments
11.2 Teva
11.2.1 Teva Company Details
11.2.2 Teva Business Overview
11.2.3 Teva Injectable Peptides Introduction
11.2.4 Teva Revenue in Injectable Peptides Business (2024-2024)
11.2.5 Teva Recent Developments
11.3 Novo Nordisk
11.3.1 Novo Nordisk Company Details
11.3.2 Novo Nordisk Business Overview
11.3.3 Novo Nordisk Injectable Peptides Introduction
11.3.4 Novo Nordisk Revenue in Injectable Peptides Business (2024-2024)
11.3.5 Novo Nordisk Recent Developments
11.4 Takeda
11.4.1 Takeda Company Details
11.4.2 Takeda Business Overview
11.4.3 Takeda Injectable Peptides Introduction
11.4.4 Takeda Revenue in Injectable Peptides Business (2024-2024)
11.4.5 Takeda Recent Developments
11.5 Eli Lilly
11.5.1 Eli Lilly Company Details
11.5.2 Eli Lilly Business Overview
11.5.3 Eli Lilly Injectable Peptides Introduction
11.5.4 Eli Lilly Revenue in Injectable Peptides Business (2024-2024)
11.5.5 Eli Lilly Recent Developments
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Injectable Peptides Introduction
11.6.4 AstraZeneca Revenue in Injectable Peptides Business (2024-2024)
11.6.5 AstraZeneca Recent Developments
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Novartis Business Overview
11.7.3 Novartis Injectable Peptides Introduction
11.7.4 Novartis Revenue in Injectable Peptides Business (2024-2024)
11.7.5 Novartis Recent Developments
11.8 AbbVie
11.8.1 AbbVie Company Details
11.8.2 AbbVie Business Overview
11.8.3 AbbVie Injectable Peptides Introduction
11.8.4 AbbVie Revenue in Injectable Peptides Business (2024-2024)
11.8.5 AbbVie Recent Developments
11.9 Ipsen
11.9.1 Ipsen Company Details
11.9.2 Ipsen Business Overview
11.9.3 Ipsen Injectable Peptides Introduction
11.9.4 Ipsen Revenue in Injectable Peptides Business (2024-2024)
11.9.5 Ipsen Recent Developments
11.10 Ferring
11.10.1 Ferring Company Details
11.10.2 Ferring Business Overview
11.10.3 Ferring Injectable Peptides Introduction
11.10.4 Ferring Revenue in Injectable Peptides Business (2024-2024)
11.10.5 Ferring Recent Developments
11.11 Merck
11.11.1 Merck Company Details
11.11.2 Merck Business Overview
11.11.3 Merck Injectable Peptides Introduction
11.11.4 Merck Revenue in Injectable Peptides Business (2024-2024)
11.11.5 Merck Recent Developments
11.12 The Medicines
11.12.1 The Medicines Company Details
11.12.2 The Medicines Business Overview
11.12.3 The Medicines Injectable Peptides Introduction
11.12.4 The Medicines Revenue in Injectable Peptides Business (2024-2024)
11.12.5 The Medicines Recent Developments
11.13 Roche
11.13.1 Roche Company Details
11.13.2 Roche Business Overview
11.13.3 Roche Injectable Peptides Introduction
11.13.4 Roche Revenue in Injectable Peptides Business (2024-2024)
11.13.5 Roche Recent Developments
11.14 J & J
11.14.1 J & J Company Details
11.14.2 J & J Business Overview
11.14.3 J & J Injectable Peptides Introduction
11.14.4 J & J Revenue in Injectable Peptides Business (2024-2024)
11.14.5 J & J Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Injectable Peptides Market Size Growth Rate by Type (US$ Million), 2024 VS 2022 VS 2034
Table 2. Key Players of Brand
Table 3. Key Players of Generic Drug
Table 4. Global Injectable Peptides Market Size Growth Rate by Application (US$ Million), 2024 VS 2022 VS 2034
Table 5. Global Injectable Peptides Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 6. Global Injectable Peptides Market Size by Region (2024-2024) & (US$ Million)
Table 7. Global Injectable Peptides Market Share by Region (2024-2024)
Table 8. Global Injectable Peptides Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 9. Global Injectable Peptides Market Share by Region (2024-2034)
Table 10. Injectable Peptides Market Trends
Table 11. Injectable Peptides Market Drivers
Table 12. Injectable Peptides Market Challenges
Table 13. Injectable Peptides Market Restraints
Table 14. Global Injectable Peptides Revenue by Players (2024-2024) & (US$ Million)
Table 15. Global Injectable Peptides Revenue Share by Players (2024-2024)
Table 16. Global Top Injectable Peptides by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injectable Peptides as of 2022)
Table 17. Global Injectable Peptides Industry Ranking 2021 VS 2022 VS 2024
Table 18. Global 5 Largest Players Market Share by Injectable Peptides Revenue (CR5 and HHI) & (2024-2024)
Table 19. Global Key Players of Injectable Peptides, Headquarters and Area Served
Table 20. Global Key Players of Injectable Peptides, Product and Application
Table 21. Global Key Players of Injectable Peptides, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Injectable Peptides Market Size by Type (2024-2024) & (US$ Million)
Table 24. Global Injectable Peptides Revenue Market Share by Type (2024-2024)
Table 25. Global Injectable Peptides Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 26. Global Injectable Peptides Revenue Market Share by Type (2024-2034)
Table 27. Global Injectable Peptides Market Size by Application (2024-2024) & (US$ Million)
Table 28. Global Injectable Peptides Revenue Share by Application (2024-2024)
Table 29. Global Injectable Peptides Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 30. Global Injectable Peptides Revenue Share by Application (2024-2034)
Table 31. North America Injectable Peptides Market Size by Type (2024-2024) & (US$ Million)
Table 32. North America Injectable Peptides Market Size by Type (2024-2034) & (US$ Million)
Table 33. North America Injectable Peptides Market Size by Application (2024-2024) & (US$ Million)
Table 34. North America Injectable Peptides Market Size by Application (2024-2034) & (US$ Million)
Table 35. North America Injectable Peptides Growth Rate (CAGR) by Country (US$ Million): 2024 VS 2022 VS 2034
Table 36. North America Injectable Peptides Market Size by Country (2024-2024) & (US$ Million)
Table 37. North America Injectable Peptides Market Size by Country (2024-2034) & (US$ Million)
Table 38. Europe Injectable Peptides Market Size by Type (2024-2024) & (US$ Million)
Table 39. Europe Injectable Peptides Market Size by Type (2024-2034) & (US$ Million)
Table 40. Europe Injectable Peptides Market Size by Application (2024-2024) & (US$ Million)
Table 41. Europe Injectable Peptides Market Size by Application (2024-2034) & (US$ Million)
Table 42. Europe Injectable Peptides Growth Rate (CAGR) by Country (US$ Million): 2024 VS 2022 VS 2034
Table 43. Europe Injectable Peptides Market Size by Country (2024-2024) & (US$ Million)
Table 44. Europe Injectable Peptides Market Size by Country (2024-2034) & (US$ Million)
Table 45. China Injectable Peptides Market Size by Type (2024-2024) & (US$ Million)
Table 46. China Injectable Peptides Market Size by Type (2024-2034) & (US$ Million)
Table 47. China Injectable Peptides Market Size by Application (2024-2024) & (US$ Million)
Table 48. China Injectable Peptides Market Size by Application (2024-2034) & (US$ Million)
Table 49. Asia Injectable Peptides Market Size by Type (2024-2024) & (US$ Million)
Table 50. Asia Injectable Peptides Market Size by Type (2024-2034) & (US$ Million)
Table 51. Asia Injectable Peptides Market Size by Application (2024-2024) & (US$ Million)
Table 52. Asia Injectable Peptides Market Size by Application (2024-2034) & (US$ Million)
Table 53. Asia Injectable Peptides Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 54. Asia Injectable Peptides Market Size by Region (2024-2024) & (US$ Million)
Table 55. Asia Injectable Peptides Market Size by Region (2024-2034) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Injectable Peptides Market Size by Type (2024-2024) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Injectable Peptides Market Size by Type (2024-2034) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Injectable Peptides Market Size by Application (2024-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Injectable Peptides Market Size by Application (2024-2034) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Injectable Peptides Growth Rate (CAGR) by Country (US$ Million): 2024 VS 2022 VS 2034
Table 61. Middle East, Africa, and Latin America Injectable Peptides Market Size by Country (2024-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Injectable Peptides Market Size by Country (2024-2034) & (US$ Million)
Table 63. Sanofi Company Details
Table 64. Sanofi Business Overview
Table 65. Sanofi Injectable Peptides Product
Table 66. Sanofi Revenue in Injectable Peptides Business (2024-2024) & (US$ Million)
Table 67. Sanofi Recent Developments
Table 68. Teva Company Details
Table 69. Teva Business Overview
Table 70. Teva Injectable Peptides Product
Table 71. Teva Revenue in Injectable Peptides Business (2024-2024) & (US$ Million)
Table 72. Teva Recent Developments
Table 73. Novo Nordisk Company Details
Table 74. Novo Nordisk Business Overview
Table 75. Novo Nordisk Injectable Peptides Product
Table 76. Novo Nordisk Revenue in Injectable Peptides Business (2024-2024) & (US$ Million)
Table 77. Novo Nordisk Recent Developments
Table 78. Takeda Company Details
Table 79. Takeda Business Overview
Table 80. Takeda Injectable Peptides Product
Table 81. Takeda Revenue in Injectable Peptides Business (2024-2024) & (US$ Million)
Table 82. Takeda Recent Developments
Table 83. Eli Lilly Company Details
Table 84. Eli Lilly Business Overview
Table 85. Eli Lilly Injectable Peptides Product
Table 86. Eli Lilly Revenue in Injectable Peptides Business (2024-2024) & (US$ Million)
Table 87. Eli Lilly Recent Developments
Table 88. AstraZeneca Company Details
Table 89. AstraZeneca Business Overview
Table 90. AstraZeneca Injectable Peptides Product
Table 91. AstraZeneca Revenue in Injectable Peptides Business (2024-2024) & (US$ Million)
Table 92. AstraZeneca Recent Developments
Table 93. Novartis Company Details
Table 94. Novartis Business Overview
Table 95. Novartis Injectable Peptides Product
Table 96. Novartis Revenue in Injectable Peptides Business (2024-2024) & (US$ Million)
Table 97. Novartis Recent Developments
Table 98. AbbVie Company Details
Table 99. AbbVie Business Overview
Table 100. AbbVie Injectable Peptides Product
Table 101. AbbVie Revenue in Injectable Peptides Business (2024-2024) & (US$ Million)
Table 102. AbbVie Recent Developments
Table 103. Ipsen Company Details
Table 104. Ipsen Business Overview
Table 105. Ipsen Injectable Peptides Product
Table 106. Ipsen Revenue in Injectable Peptides Business (2024-2024) & (US$ Million)
Table 107. Ipsen Recent Developments
Table 108. Ferring Company Details
Table 109. Ferring Business Overview
Table 110. Ferring Injectable Peptides Product
Table 111. Ferring Revenue in Injectable Peptides Business (2024-2024) & (US$ Million)
Table 112. Ferring Recent Developments
Table 113. Merck Company Details
Table 114. Merck Business Overview
Table 115. Merck Injectable Peptides Product
Table 116. Merck Revenue in Injectable Peptides Business (2024-2024) & (US$ Million)
Table 117. Merck Recent Developments
Table 118. The Medicines Company Details
Table 119. The Medicines Business Overview
Table 120. The Medicines Injectable Peptides Product
Table 121. The Medicines Revenue in Injectable Peptides Business (2024-2024) & (US$ Million)
Table 122. The Medicines Recent Developments
Table 123. Roche Company Details
Table 124. Roche Business Overview
Table 125. Roche Injectable Peptides Product
Table 126. Roche Revenue in Injectable Peptides Business (2024-2024) & (US$ Million)
Table 127. Roche Recent Developments
Table 128. J & J Company Details
Table 129. J & J Business Overview
Table 130. J & J Injectable Peptides Product
Table 131. J & J Revenue in Injectable Peptides Business (2024-2024) & (US$ Million)
Table 132. J & J Recent Developments
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Injectable Peptides Market Size Growth Rate by Type, 2024 VS 2022 VS 2034 (US$ Million)
Figure 2. Global Injectable Peptides Market Share by Type: 2022 VS 2034
Figure 3. Brand Features
Figure 4. Generic Drug Features
Figure 5. Global Injectable Peptides Market Size Growth Rate by Application, 2024 VS 2022 VS 2034 (US$ Million)
Figure 6. Global Injectable Peptides Market Share by Application: 2022 VS 2034
Figure 7. Cancer Case Studies
Figure 8. Metabolic Disorders Case Studies
Figure 9. Central Nervous System Case Studies
Figure 10. Other Case Studies
Figure 11. Injectable Peptides Report Years Considered
Figure 12. Global Injectable Peptides Market Size (US$ Million), Year-over-Year: 2024-2034
Figure 13. Global Injectable Peptides Market Size, (US$ Million), 2024 VS 2022 VS 2034
Figure 14. Global Injectable Peptides Market Share by Region: 2022 VS 2034
Figure 15. Global Injectable Peptides Market Share by Players in 2022
Figure 16. Global Top Injectable Peptides Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injectable Peptides as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Injectable Peptides Revenue in 2022
Figure 18. North America Injectable Peptides Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 19. North America Injectable Peptides Market Share by Type (2024-2034)
Figure 20. North America Injectable Peptides Market Share by Application (2024-2034)
Figure 21. North America Injectable Peptides Market Share by Country (2024-2034)
Figure 22. United States Injectable Peptides Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 23. Canada Injectable Peptides Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 24. Europe Injectable Peptides Market Size YoY (2024-2034) & (US$ Million)
Figure 25. Europe Injectable Peptides Market Share by Type (2024-2034)
Figure 26. Europe Injectable Peptides Market Share by Application (2024-2034)
Figure 27. Europe Injectable Peptides Market Share by Country (2024-2034)
Figure 28. Germany Injectable Peptides Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 29. France Injectable Peptides Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 30. U.K. Injectable Peptides Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 31. Italy Injectable Peptides Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 32. Russia Injectable Peptides Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 33. Nordic Countries Injectable Peptides Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 34. China Injectable Peptides Market Size YoY (2024-2034) & (US$ Million)
Figure 35. China Injectable Peptides Market Share by Type (2024-2034)
Figure 36. China Injectable Peptides Market Share by Application (2024-2034)
Figure 37. Asia Injectable Peptides Market Size YoY (2024-2034) & (US$ Million)
Figure 38. Asia Injectable Peptides Market Share by Type (2024-2034)
Figure 39. Asia Injectable Peptides Market Share by Application (2024-2034)
Figure 40. Asia Injectable Peptides Market Share by Region (2024-2034)
Figure 41. Japan Injectable Peptides Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 42. South Korea Injectable Peptides Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 43. China Taiwan Injectable Peptides Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 44. Southeast Asia Injectable Peptides Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 45. India Injectable Peptides Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 46. Australia Injectable Peptides Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Injectable Peptides Market Size YoY (2024-2034) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Injectable Peptides Market Share by Type (2024-2034)
Figure 49. Middle East, Africa, and Latin America Injectable Peptides Market Share by Application (2024-2034)
Figure 50. Middle East, Africa, and Latin America Injectable Peptides Market Share by Country (2024-2034)
Figure 51. Brazil Injectable Peptides Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 52. Mexico Injectable Peptides Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 53. Turkey Injectable Peptides Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 54. Saudi Arabia Injectable Peptides Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 55. Israel Injectable Peptides Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 56. GCC Countries Injectable Peptides Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 57. Sanofi Revenue Growth Rate in Injectable Peptides Business (2024-2024)
Figure 58. Teva Revenue Growth Rate in Injectable Peptides Business (2024-2024)
Figure 59. Novo Nordisk Revenue Growth Rate in Injectable Peptides Business (2024-2024)
Figure 60. Takeda Revenue Growth Rate in Injectable Peptides Business (2024-2024)
Figure 61. Eli Lilly Revenue Growth Rate in Injectable Peptides Business (2024-2024)
Figure 62. AstraZeneca Revenue Growth Rate in Injectable Peptides Business (2024-2024)
Figure 63. Novartis Revenue Growth Rate in Injectable Peptides Business (2024-2024)
Figure 64. AbbVie Revenue Growth Rate in Injectable Peptides Business (2024-2024)
Figure 65. Ipsen Revenue Growth Rate in Injectable Peptides Business (2024-2024)
Figure 66. Ferring Revenue Growth Rate in Injectable Peptides Business (2024-2024)
Figure 67. Merck Revenue Growth Rate in Injectable Peptides Business (2024-2024)
Figure 68. The Medicines Revenue Growth Rate in Injectable Peptides Business (2024-2024)
Figure 69. Roche Revenue Growth Rate in Injectable Peptides Business (2024-2024)
Figure 70. J & J Revenue Growth Rate in Injectable Peptides Business (2024-2024)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries